In August, Mediclinic's board had unanimously approved a revised offer from its biggest shareholder, Remgro, in a consortium with Switzerland’s MSC Mediterranean Shipping, that values its shares at £3.7 billion .Valued at over R86 billion on the JSE, Mediclinic operates in Switzerland, the Middle East and in southern Africa, generating about 45% of its revenue in the European country, with roughly equal contributions from its other two operating regions.
Shares in Mediclinic were up almost 2% on Tuesday, and have climbed by almost two-thirds over the past one year. The revised 504p per share offer had represented about a 35% premium to the group's closing share price on 25 May 2022, the day before an initial offer was made.We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed.